Navigation Links
Pacira Pharmaceuticals, Inc. Announces EXPAREL™ Data Presentations at the International Anesthesia Research Society 2011 Annual Meeting
Date:5/23/2011

lly disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

Contacts:

James S. Scibetta
Chief Financial Officer
Pacira Pharmaceuticals, Inc.
(973) 254-3570

Dan Budwick
Vice President, Media Relations
Pure Communications, Inc.
(973) 271-6085


'/>"/>
SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
2. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA)
3. Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment
4. Pacira Pharmaceuticals Announces FDA Acceptance of EXPAREL™ New Drug Application for Pain Management
5. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
6. Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
7. Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
8. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
9. Pacira Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
10. Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results
11. Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)...  BD (Becton, Dickinson and Company) (NYSE: BDX ... it will present at the Deutsche Bank 38 th ... 10:40 a.m. (ET). A live webcast of ... at www.bd.com/investors and will be available for replay ... BD is a leading global medical technology company ...
(Date:5/24/2013)... 24, 2013 Solta Medical, Inc. (NASDAQ: ... today reported Dr. Edward W. Knowlton ... Directors effective immediately.  Dr. Knowlton is the founder of Thermage, ... a director since 1996. "On behalf of the ... I would like to thank Ed for his tireless dedication ...
(Date:5/24/2013)... , May 24, 2013  Heska Corporation (NASDAQ: HSKA, "Heska" ... specialty products, announced today that Dr. Robert Grieve ... Jason Napolitano , executive vice president and ... MicroCap Conference, which is being held May 30, 2013 in ... Hyatt Hotel. The Company,s presentation is scheduled ...
Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2
... as Associate MemberWASHINGTON, Jan. 13 The Association ... clinical outsourcing industry to regulators, biopharmaceutical clients, policy ... worldwide, today announced that it has elected Dr. ... William Sharbaugh as Chair-Elect. Dr. Winstanly, MBChB, Executive ...
... /PRNewswire-FirstCall/ - - Uroplasty, Inc. (Amex: ... study of Macroplastique for the treatment of female stress ... Journal of Urology . This is the first, large, ... Macroplastique to another bulking agent used in the control ...
Cached Medicine Technology:Dr. Derek Winstanly of Quintiles to Serve as 2009 ACRO Chair; Mr. William Sharbaugh of PPD to Be Chair-Elect 2Uroplasty Highlights Results From Clinical Study on Macroplastique(R) for the Treatment of Stress Urinary Incontinence 2Uroplasty Highlights Results From Clinical Study on Macroplastique(R) for the Treatment of Stress Urinary Incontinence 3
(Date:5/25/2013)... NYC,NY (PRWEB) May 25, 2013 Dr. ... only non-invasive procedure FDA-approved to lift skin on the neck, ... available at her practice, Medical Aesthetics. , Ultherapy is a ... body’s own natural healing process to lift the skin over ... the first time, to see and then treat the deepest ...
(Date:5/25/2013)... York (PRWEB) May 25, 2013 Life ... which are used to detect and create a new ... test reading and are also known as biotechnology reagents. ... bioscience, diagnosis and education. , This market is driven ... reagents in the field of therapeutics, growth in research ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 A disorder ... type of peripheral neuropathy. According to neuropathy expert doctor ... it is estimated that the disorder affects almost 50% ... complication arising from Diabetes. The high blood sugar levels ... and patients suffering from it usually tend to have ...
(Date:5/25/2013)... May 25 (HealthDay News) -- Many viruses and parasites ... and leptospirosis -- a bacteria-borne illness than can result ... at dog parks, according to a veterinarian. ... and even the air, said Dr. Susan Nelson, a ... Center. "Many of these serious diseases can be fatal, ...
(Date:5/25/2013)... May 25, 2013 The report ... By Types, Functions, Applications, Ingredients, Shell Materials, Packaging, ... the global food encapsulation market with analysis and ... It also identifies the driving and restraining factors ... of trends, opportunities, and challenges. The market is ...
Breaking Medicine News(10 mins):Health News:Dr. Leslie Gerstman Is Now Offering the Non-surgical Facelifting Procedure – Ultherapy – in NYC and NJ 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 2Health News:Life Sciences And Analytical Reagents Market - New Industry Research Report is Now Available for Pre-Order at Transparency Market Research 3Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2Health News:Hidden Dangers Dog Dog Parks 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 2Health News:Food Encapsulation Market to Reach $42 Billion by 2016 - New Report by MarketsandMarkets 3
... access to high-quality, evidence-based care for behavioral health,conditions ... The,"Mental Health Parity Act of 2007" would require ... parity with respect to all financial,requirements and all ... "AHIP applauds the Senate for coming together ...
... Ga., Sept. 19 Dominium Benefits, LLC,continues its ... its team. "We are very excited to include ... further our ability to provide,successful results for our ... Benefits, LLC, the next generation employee benefits brokerage,and ...
... Each year in the U.S. millions of blood donors ... down the drain. Of the 14.4 million units of ... the four million whole blood-derived platelet concentrates are discarded. ... much more expensive single donor (apheresis) platelets. Yet there ...
... Sept. 19 On a routine stop at,the supermarket ... the left side of her head on the cement ... brain. The injury left her with language and hearing,impairments, ... or most of the three weeks she was in ...
... Young Children in U.S. ... Available for 2007-2008 Flu Season, GAITHERSBURG, Md., Sept. 19 ... has approved the,expanded use of FluMist(R) (Influenza Virus Vaccine Live, Intranasal) ... for active,immunization for the prevention of disease caused by influenza A ...
... September 19, 2007 Naltrexone is one of ... and Drug Administration (FDA) for the treatment of ... of alcohol dependence supported by the National Institute ... Study, suggested that naltrexone produced a modest but ...
Cached Medicine News:Health News:Critical blood shortages eased by new technology 2Health News:Critical blood shortages eased by new technology 3Health News:CIGNA Group Insurance Celebrates Return to Work Success During National Rehabilitation Awareness Week 2Health News:CIGNA Group Insurance Celebrates Return to Work Success During National Rehabilitation Awareness Week 3Health News:FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age 2Health News:FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age 3Health News:FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age 4Health News:FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age 5Health News:Family history of alcoholism affects response to drug used to treat heavy drinking 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: